No black box warning on record for Feraheme

As of the latest FDA labeling reviewed, Feraheme (FERUMOXYTOL) does not carry a black box warning. Standard warnings and precautions still apply — see the full Feraheme medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Greater risk of anaphylaxis in patients with multiple drug allergies. ( 5.1 ) • Hypotension: Feraheme may cause hypotension. Monitor for signs and symptoms of hypotension following each administration of Feraheme. ( 5.2 ) • Iron Overload: Regularly monitor hematologic responses during Feraheme therapy. Do not administer Feraheme to patients with iron overload. ( 5.3 )

No black box warning on record for Feraheme

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Greater risk of anaphylaxis in patients with multiple drug allergies. ( 5.1 ) • Hypotension: Feraheme may cause hypotension. Monitor for signs and symptoms of hypotension following each administration of Feraheme. ( 5.2 ) • Iron Overload: Regularly monitor hematologic responses during Feraheme therapy. Do not administer Feraheme to patients with iron overload. ( 5.3 )

Feraheme Black Box Warning

No black box warning on record for Feraheme

Other warnings & precautions

Feraheme Black Box Warning

No black box warning on record for Feraheme

Other warnings & precautions